Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.04.2015 | Case report

Afatinib/cetuximab

Rash in an elderly patient: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

An elderly man developed a rash following treatment with afatinib and cetuximab for EGFR and PIK3CA mutant non-small cell lung cancer [patient age at reaction onset not stated]. …
Literatur
Zurück zum Zitat Lammers PE, et al. A patient with metastatic lung adenocarcinoma harboring concurrent EGFR L858R, EGFR germline T790M, and PIK3CA mutations: The challenge of interpreting results of comprehensive mutational testing in lung cancer. Journal of the National Comprehensive Cancer Network 12: 6-11, No. 1, Jan 2014 - USAPubMedCentralPubMed Lammers PE, et al. A patient with metastatic lung adenocarcinoma harboring concurrent EGFR L858R, EGFR germline T790M, and PIK3CA mutations: The challenge of interpreting results of comprehensive mutational testing in lung cancer. Journal of the National Comprehensive Cancer Network 12: 6-11, No. 1, Jan 2014 - USAPubMedCentralPubMed
Metadaten
Titel
Afatinib/cetuximab
Rash in an elderly patient: case report
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9841-4

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Temozolomide

Case report

Antiretrovirals

Case report

Aspirin/warfarin

Case report

Bisphosphonates